Analyst Ratings for Relmada Therapeutics Inc (RLMD)
RLMD Rating Summary
RLMD Price Target Summary
- Highest: $19.00 (Mizuho)
- Lowest: $8.00 (Leerink)
- Average: $12.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$12.33 (+132.7%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/18/2026 | H.C. Wainwright » Updated 6/23/2026 |
Andres Maldonado | New Coverage | Buy (N/A) |
12.00 (N/A) |
6.60 (5.30) |
-19.7% | Details |
| 3/24/2026 | Piper Sandler | Kelsey Goodwin | New Coverage | Overweight (N/A) |
12.00 (N/A) |
6.07 (5.30) |
-12.69% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
